Maria Lucia Lemos Lopes

Maria Lucia Lemos Lopes

Auto-generated profile, based on publicly available information

Maria Lucia Lemos Lopes

Disciplina de Especialidades Clínicas, Departamento de Clínica Médica, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
VTVirginia Fernandes Moça Trevisani
Virginia Fernandes Moça Trevisani
APAlisson Pugliesi
Alisson Pugliesi
SPSandra Gofinet Pasoto
Sandra Gofinet Pasoto
MLMaria Lucia Lemos Lopes
Maria Lucia Lemos Lopes
LGLissiane Noronha Guedes
Lissiane Noronha Guedes
VVValeria Valim
Valeria Valim
Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, these systemic manifestations are not routinely evaluated and there is no homogenous approach to their diagnosis or evaluation. To close this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of these manifestations and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. The first part of this guideline summarizes the most important topics, and 11 recommendations are provided for the articular, pulmonary, and renal care of SS patients.

10 October 2022 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
VTVirginia Fernandes Moça Trevisani
Virginia Fernandes Moça Trevisani
APAysa César Pinheiro
Aysa César Pinheiro
SFSonia Cristina de Magalhães Souza Fialho
Sonia Cristina de Magalhães Souza Fialho
MFMarilena Leal Mesquita Silvestre Fernandes
Marilena Leal Mesquita Silvestre Fernandes
APAlisson Pugliesi
Alisson Pugliesi
VVValeria Valim
Valeria Valim
Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.

11 February 2025 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
FOFabiola Reis Oliveira
Fabiola Reis Oliveira
SASimone Appenzeller
Simone Appenzeller
SPSandra Gofinet Pasoto
Sandra Gofinet Pasoto
MFMarilena Leal Mesquita Silvestre Fernandes
Marilena Leal Mesquita Silvestre Fernandes
MLMaria Lucia Lemos Lopes
Maria Lucia Lemos Lopes
VTVirginia Fernandes Moça Trevisani
Virginia Fernandes Moça Trevisani
Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.

9 July 2024 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
APAlisson Pugliesi
Alisson Pugliesi
DEDanielle Christinne Soares Do Egypto
Danielle Christinne Soares Do Egypto
GDGuilherme Duffles
Guilherme Duffles
DCDiego Ustárroz Cantali
Diego Ustárroz Cantali
SPSandra Gofinet Pasoto
Sandra Gofinet Pasoto
VTVirginia Fernandes Moça Trevisani
Virginia Fernandes Moça Trevisani
Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.

3 June 2024 in Advances in Rheumatology
Verified
Journal Article
Open access
PDF file
RCRafael Coradin
Rafael Coradin
MLMaria Lúcia Lemos Lopes
Maria Lúcia Lemos Lopes
JGJoão Carlos Goldani
João Carlos Goldani
PVPedro Enrico Ventura
Pedro Enrico Ventura
EKElizete Keitel
Elizete Keitel
Introduction: Sjögren’s disease (SD) is an immune-mediated chronic inflammatory disease that affects epithelial tissues, mainly salivary and lacrimal glands. It also presents extraglandular manifestations. The main renal manifestation is tubulointerstitial nephritis (TIN), which can manifest as renal tubular acidosis (RTA). Urinary citrate may be a biomarker of RTA in these patients. The objective of this study was to evaluate whether hypocitraturia is a predictive biomarker of RTA in a sample of patients with SD in a tertiary hospital in southern Brazil. Methods: All patients with SD who met the inclusion criteria and who participated in the rheumatology outpatient clinic of the Irmandade Santa Casa de Misericórdia de Porto Alegre were included. Demographic, SD, serological and urinary data were obtained. RTA was considered in those patients who persistently presented urinary pH above 5.5 and serum pH below 7.35. Patients who persistently had urinary pH above 5.5 underwent a urinary acidification test with furosemide and fludrocortisone. These patients received 1 mg of fludrocortisone and 40 mg of furosemide and had their urine samples tested 2, 4 and 6 h after taking the medications. The test was stopped at any urine sample with pH 5.5 or less. The variables were expressed as mean and standard deviation or interquartile range. The association between hypocitraturia and RTA was assessed using the chi-square. Results: Forty-two patients were included, 95.2% female with a median age of 61.73 years. The prevalence of complete distal RTA was 4.88%. Twenty-eight patients underwent urine acidification testing. Five patients had hypocitraturia, and two of them had complete distal RTA. The association between hypocitraturia and RTA was statistically significant (p < 0.012), with a sensitivity of 100%, specificity of 91.2% and accuracy of 91.7%. The negative predictive value was 100%. The global renal assessment of the population demonstrated two patients with RTA, one patient with decreased renal function and six patients with proteinuria greater than 0.5 g/24 h. Conclusion: The prevalence of RTA in the studied population was 4.88%. Hypocitraturia had high sensitivity and accuracy for the diagnosis of RTA.

1 January 2021
Verified
Conference Paper
Open access
GSGilberto Scanagatta
Gilberto Scanagatta
TTTatiana Freitas Tourinho
Tatiana Freitas Tourinho
MLMaria Lúcia Lemos Lopes
Maria Lúcia Lemos Lopes
MHMaria Odete Esteves Hilario
Maria Odete Esteves Hilario
EOEduardo Rosa de Oliveira
Eduardo Rosa de Oliveira
LCLuana Ribeiro Carlos
Luana Ribeiro Carlos